Bannerstone Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
1,836
-47
-2% -$48K 1.85% 14
2026
Q1
$1.73M Buy
1,883
+53
+3% +$53.7K 1.61% 13
2025
Q4
$1.97M Buy
+1,830
New +$1.75M 1.89% 10

Other funds holding LLY

Bannerstone Capital Management's LLY Position: Q2 2026 in Review

Bannerstone Capital Management reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $48K and leaving 1,836 shares worth $2.2M. The position accounts for 1.85% of the portfolio, ranked #14.

Bannerstone Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bannerstone Capital Management held 1,836 shares of Eli Lilly worth $2.2M as of Q2 2026.
  • Bannerstone Capital Management sold 47 Eli Lilly shares in Q2 2026, an estimated $48K.
  • Eli Lilly made up 1.85% of Bannerstone Capital Management's portfolio in Q2 2026, its #14 holding.
  • Bannerstone Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bannerstone Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.